CVS Health Corp (CVS)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $113.35B
Last updated: Nov 17, 2026 at 4:40 PM ET
CVS Health Corp (CVS) Stock Chart
CVS Health (CVS) has a latest price of $85.80 on Nov 17, 2026, 21.4% below its 52-week high of $109.22. Its price rose 11.2% over the past 12 months. The month-end price rose 7.3% over the 10 years through Oct 2026, a compound annual rate of 0.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $106.51 in Jan 2022 and its lowest $44.89 in Dec 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CVS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CVS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 7.7%, and over 6 months it fell 8.3%. The month-end price rose 30.8% over the 3 years through Oct 2026, a compound annual rate of 9.4%.
| Period | Change |
|---|---|
| 1 month | -6.8% |
| 3 months | -7.7% |
| 6 months | -8.3% |
| 12 months | +11.2% |
| 12 months, with dividends | +14.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +30.8% | +9.4% |
| 5 years | +1.1% | +0.2% |
| 10 years | +7.3% | +0.7% |
Price by Year
Its best calendar year was 2025, when the price rose 76.8%, and its weakest was 2024, when it fell 43.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $90.25 | +13.7% |
| 2025 | $79.36 | +76.8% |
| 2024 | $44.89 | -43.1% |
| 2023 | $78.96 | -15.3% |
| 2022 | $93.19 | -9.7% |
| 2021 | $103.16 | +51.0% |
| 2020 | $68.30 | -8.1% |
| 2019 | $74.29 | +13.4% |
| 2018 | $65.52 | -9.6% |
| 2017 | $72.50 | -8.1% |
Trading Range
The price is 3.5% below its 50-day average of $88.90 and 3.1% below its 200-day average of $88.52.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $85.80 | |
| 52-week high | $109.22 | -21.4% |
| 52-week low | $67.99 | +26.2% |
| 50-day average | $88.90 | -3.5% |
| 200-day average | $88.52 | -3.1% |
Price Risk
Over 3 years, its largest fall from a peak was 44.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.00 |
| Largest fall, 1 year | -26.7% |
| Largest fall, 3 years | -44.0% |
Valuation
CVS Health traded at 11.8x earnings at the end of 2025, against a 5-year median of 10.6x and a 10-year median of 10.4x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CVS
What is CVS's 1-year price change?
CVS Health's price rose 11.2% over the past 12 months. With dividends included, the 12-month total return was 14.6%.
What is CVS's 5-year price change?
CVS Health's month-end price rose 1.1% over the 5 years through Oct 2026, a compound annual rate of 0.2%. These figures leave out dividends.
What is CVS's 52-week high and low?
CVS Health's 52-week high is $109.22 and its 52-week low is $67.99. Its latest price of $85.80 on Nov 17, 2026 is 21.4% below the high.
What is CVS's beta?
CVS Health's 1-year beta against the S&P 500 is 0.00, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 26.7%.
Is the CVS chart free?
Yes. Advanced Charting for CVS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CVS pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts